Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration

Blood

Volumn 100, Issue 7, 2002, Pages 2479-2486

  Johnson Léger, Caroline A ^a,b,c   Aurrand Lions, Michel ^a,b,c   Beltraminelli, Nicola ^a,b,c   Fasel, Nicolas ^a,b,c   Imhof, Beat A ^a,b,c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Chemin des Croisettes 22   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; JUNCTIONAL ADHESION MOLECULE 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY JAM2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRAVASATION; GENETIC TRANSFECTION; HEMANGIOENDOTHELIOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LYMPH NODE; LYMPHOCYTE MIGRATION; MIGRATION INHIBITION; MOLECULAR CLONING; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; TONSIL; UMBILICAL VEIN;

EID: 0036785376     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2001-11-0098     Document Type: Article

References (39)

1. Ager A. Lymphocyte recirculation and homing: roles of adhesion molecules and chemoattractants. Trends Cell Biol. 1994;4:326-333.
2. Pabst R, Binns RM. Heterogeneity of lymphocyte homing physiology: several mechanisms operate in the control of migration to lymphoid and nonlymphoid organs in vivo. Immunol Rev. 1989;108:83-109.
3. Salmi M, Jalkanen S. How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing. Adv Immunol. 1997;64:139-218.
4. Imhof BA, Dunon D. Leukocyte migration and adhesion. Adv Immunol. 1995;58:345-416.
5. Dejana E, Corada M, Lampugnani MG. Endothelial cell-to-cell junctions. FASEB J. 1995;9:910-918.
6. Johnson-Léger C, Aurrand-Lions M, Imhof BA. The parting of the endothelium: miracle, or simply a junctional affair? J Cell Sci. 2000;113:921-933.
7. Vestweber D. Molecular mechanisms that control endothelial cell contacts. J Pathol. 2000;190:281-291.
8. Anderson AO, Anderson ND. Lymphocyte emigration from high endothelial venules in rat lymph nodes. Immunology. 1976;31:731-748.
9. Anderson ND, Anderson AO, Wyllie RG. Specialized structure and metabolic activities of high endothelial venules in rat lymphatic tissues. Immunology. 1976;31:455-473.
10. Kraal G, Mebius RE. High endothelial venules: lymphocyte traffic control and controlled traffic. Adv Immunol. 1997;65:347-395.
11. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84:2068-2101.
12. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
13. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science. 1996;272:60-66,
14. Feng D, Nagy JA, Pyne K, Dvorak HF, Dvorak AM. Neutrophils emigrate from venules by a transendothelial cell pathway in response to FMLP. J Exp Med. 1998;187:903-915.
15. Girard JP, Springer TA. High endothelial venules (HEV): specialized endothelium for lymphocyte migration. Immunol Today. 1995;16:449-457.
16. Aurrand-Lions MA, Duncan L, Ballestrem C, Imhof BA. JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells. J Biol Chem. 2001;276:2733-2741.
17. Martin-Padura I, Lostaglio S, Schneemann M, et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol. 1998;142:117-127.
18. Palmeri D, van Zante A, Huang CC, Hemmerich S, Rosen SD. Vascular endothelial junction-associated molecule, a novel member of the immunoglobulin superfamily, is localized to intercellular boundaries of endothelial cells. J Biol Chem. 2000;275:19139-19145.
19. Aurrand-Lions M, Johnson-Leger C, Wong C, Du Pasquier L, Imhof BA. Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood. 2001;98:3699-3707.
20. Wall RT, Harker LA, Quadracci LJ, Striker GE. Factors influencing endothelial cell proliferation in vitro. J Cell Physiol. 1978;96:203-213.
21. Malergue F, Galland F, Martin F, Mansuelle P, Aurrand-Lions M, Naquet P. A novel immunoglobulin superfamily junctional molecule expressed by antigen presenting cells, endothelial cells and platelets. Mol Immunol. 1998;35:1111-1119.
22. Ozaki H, Ishii K, Horiuchi H, et al. Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. J Immunol. 1999;163:553-557.
23. Williams LA, Martin-Padura I, Dejana E, Hogg N, Simmons DL. Identification and characterisation of human junctional adhesion molecule (JAM). Mol Immunol. 1999;36:1175-1188.
24. Grant L. The sticking and emigration of white blood cells in inflammation. In: Zweifach B, Grant L, McCluskey R, eds. The Inflammatory Process. Vol 11. New York, NY: Academic Press; 1973:205-249.
25. Hurley J. Acute inflammation. Edinburgh: Churchill Livingstone; 1983.
26. Luther SA, Lopez T, Bai W, Hanahan D, Cyster JG. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity. 2000;12:471-481.
27. Burns AR, Bowden RA, MacDonell SD, et al. Analysis of tight junctions during neutrophil transendothelial migration. J Cell Sci. 2000;113:45-57.
28. Ebnet K, Schulz CU, Meyer Zu Brickwedde MK, Pendl GG, Vestweber D. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J Biol Chem. 2000;275:27979-27988.
29. Bazzoni G, Martinez-Estrada OM, Mueller F, et al. Homophilic interaction of junctional adhesion molecule. J Biol Chem. 2000;275:30970-30976.
30. Del Maschio A, De Luigi A, Martin-Padura I, et al. Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med. 1999;190:1351-1356.
31. Ostermann G, Weber KS, Zernecke A, Schroder A, Weber C. JAM-1 is a ligand of the beta2 integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol. 2002;3:151-158.
32. Aurrand-Lions MA, Duncan L, Du Pasquier L, Imhof BA. Cloning of JAM-2 and JAM-3: an emerging junctional adhesion molecular family? Curr Top Microbiol Immunol. 2000;251:91-98.
33. Cunningham SA, Arrate MP, Rodriguez JM, et al. A novel protein with homology to the junctional adhesion molecule. Characterization of leukocyte interactions. J Biol Chem. 2000;275:34750-34756.
34. Arrate MP, Rodriguez JM, Tran TM, Brock TA, Cunningham SA. Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor. J Biol Chem. 2001;276:45826-45832.
35. Liang TW, Chiu HH, Gurney A, et al. Vascular endothelial-junctional adhesion molecule (VE-JAM)/JAM 2 interacts with T, NK, and dendritic cells through JAM 3. J Immunol. 2002;168:1618-1626.
36. Ayalon O, Sabanai H, Lampugnani MG, Dejana E, Geiger B. Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells. J Cell Biol. 1994;126:247-258.
37. Wong CW, Wiedle G, Ballestrem C, et al. PE-CAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in Cis. Mol Biol Cell. 2000;11:3109-3121.
38. Muller WA, Weigl SA, Deng X, Phillips DM. PE-CAM-1 is required for transendothelial migration of leukocytes. J Exp Med. 1993;178:449-460.
39. Schenkel AR, Mamdouh Z, Chen X, Liebman RM, Muller WA. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat Immunol. 2002;3:143-150.